Added to YB: 2025-05-29
Pitch date: 2025-05-27
ICCC [bullish]
ImmuCell Corporation
-1.58%
current return
Author Info
No bio for this author
Company Info
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
Market Cap
$54.7M
Pitch Price
$6.31
Price Target
15.48 (+149%)
Dividend
N/A
EV/EBITDA
10.84
P/E
23.43
EV/Sales
2.32
Sector
Biotechnology
Category
growth
ImmuCell Corporation - $ICCC
ICCC: Market leader in calf scours (13% CAGR) with record revenue, margins improving to 45%+. FDA approval for Re-Tain mastitis treatment likely in 2025. Trading at 9x 2025E EBITDA for core business alone. Catalysts: declining R&D costs, capacity expansion to $40M. PT: $15.48 (137% upside).
Read full article (13 min)